Pharmacological inhibition of the MAPK/JNK signaling pathway rescued the impaired tumor cell invasiveness caused by BHLHE41 knockdown, suggesting that BHLHE41 primarily promotes MCF-7 cell invasion via activation of the MAPK/JNK axis [56]. The gene discussed is BHLHE41; the disease is neoplasm.